Humira
Anti-TNF therapy for hidradenitis suppurativa and psoriatic disease.
Humira (adalimumab) neutralises tumour necrosis factor alpha, a driver of hidradenitis suppurativa, plaque psoriasis and psoriatic arthritis. It is an approved option for moderate to severe hidradenitis suppurativa and may reduce inflammatory nodules and abscesses. Established tunnels can still require procedural or surgical care.
- Injection
- Route
- Weekly
- Interval
- 4–12 wks
- First results
- TNF-alpha
- Target
- Loading schedule
- Weekly maintenance
- Wound care protocol
- Surgical co-management
Diagnosed first, treated second.
TNF inhibitors carry boxed warnings for serious infections and malignancies. Tuberculosis, hepatitis and other risk factors are assessed before treatment, and monitoring continues during therapy. Care runs alongside surgical assessment where tunnels are established, plus wound care, smoking cessation support and metabolic review.
- 01Loading schedule
- 02Weekly maintenance
- 03Wound care protocol
- 04Surgical co-management
- 05Infection surveillance
- Moderate to severe hidradenitis suppurativa
- Recurrent abscesses despite antibiotics
- Moderate to severe plaque psoriasis
- Psoriatic arthritis with skin involvement
- Clear tuberculosis screening
How the treatment works
A sequence, not a single appointment — each step informs the next.
- 01
Staging
Hurley staging or psoriasis scoring, lesion counts and imaging of tunnels where indicated.
- 02
Screening
Tuberculosis and hepatitis screening, bloodwork and a full infection history.
- 03
Loading
A high initial dose, then a reducing schedule to weekly maintenance injections.
- 04
Combined care
Wound care, targeted antibiotics, surgical review and metabolic support in parallel.
Results measured, not promised.
What to expect
- 01Fewer abscesses and inflammatory nodules
- 02Less drainage, odour and pain
- 03Slower progression of tunnelling
- 04Clearance of psoriatic plaques
- 05Reduced flare frequency over time
Results, treatment timing and recovery vary by diagnosis and individual factors. This page is educational and does not replace a medical consultation or guarantee an outcome. Prescription treatment is selected after reviewing current product information, approved indications, infection and vaccination history, other medicines and drug-specific risks.
Begin with a diagnosis,
not a guess.
Share a few details and the clinic will reply with available consultation times for humira — one-to-one with Dr. Arely.
- Response
- Within 24 hours
- Consultation
- One-to-one, 45 min
- Assessment
- Trichoscopy included
- Location
- Dr. Arely Clinic
Frequently asked
No treatment cures it, but disease activity can be reduced substantially and progression slowed.
Established tunnels often require surgery; medical therapy reduces inflammation before and after.
Humira carries boxed warnings for serious infections, including tuberculosis and invasive fungal infection, and for malignancies. Screening and monitoring reduce but do not eliminate these risks.
Smoking worsens hidradenitis considerably. Cessation support is part of the treatment plan.